Easton Pharmaceuticals (EAPH) Stock Statistics & Valuation Metrics
Total Valuation
Easton Pharmaceuticals has a market cap or net worth of $1,345.00. The enterprise value is -$23187.50T.
- Market Cap
- $1,345.00
- Enterprise Value
- -$23187.50T
Share Statistics
Easton Pharmaceuticals has 1,344,933,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,344,933,000
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Easton Pharmaceuticals’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -1.97%.
- Return on Equity (ROE)
- -0.03
- Return on Assets (ROA)
- -0.02
- Return on Invested Capital (ROIC)
- -1.97%
- Return on Capital Employed (ROCE)
- -0.02
- Revenue Per Employee
- 0
- Profits Per Employee
- -31.50K
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Easton Pharmaceuticals is -0.20. Easton Pharmaceuticals’s PEG ratio is 0.00.
- PE Ratio
- -0.20
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.13
- Price to Operating Cash Flow
- -0.14
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Easton Pharmaceuticals had revenue of 0 and earned -189.00K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -189.00K
- Pretax Income
- -189.00K
- Net Income
- -189.00K
- EBITDA
- -8,328
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 214.25K and capital expenditures -56,391, giving a free cash flow of 157.86K billion.
- Operating Cash Flow
- 214.25K
- Free Cash Flow
- 157.86K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Easton Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -770.81%
- Earnings Yield
- -702.64%
Stock Price Statistics
- Beta
- 16.53
- 52-Week Price Change
- -41.18%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Easton Pharmaceuticals as a current ratio of 0.69, with Debt / Equity ratio of 35.93%
- Current Ratio
- 0.69
- Quick Ratio
- 0.69
- Debt to Market Cap
- 3.08
- Net Debt to EBITDA
- 2784284.05
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Easton Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Easton Pharmaceuticals EV to EBITDA ratio is 2784280.82, with an EV/FCF ratio of 111833.72.
- EV to Sales
- 0.00
- EV to EBITDA
- 2784280.82
- EV to Free Cash Flow
- 111833.72
- EV to Operating Cash Flow
- 122983.16
Balance Sheet
Easton Pharmaceuticals has $0.00 in cash and marketable securities with $2.84M in debt, giving a net cash position of -$2.84M billion.
- Cash & Marketable Securities
- $0.00
- Total Debt
- $2.84M
- Net Cash
- -$2.84M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Easton Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
